Spangen Laboratories Private Limited
About Spangen Laboratories Private Limited
Data last updated:
Spangen Laboratories Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 16 January 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U93030DL2008PTC172763.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vinod Suri and Deepti Ajmani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 110 DLF Tower 15 Shivaji Marg, New Delhi, Delhi, India – 110015.
As per the financials filed for FY 2017, the company reported a revenue of ₹94,957, a decline of 13% compared to the previous year. For the same year it recorded a net profit of ₹15,295 (net margin 16.1%) and EBITDA of -₹10,000 (EBITDA margin -10.5%). Revenue has declined at a compounded annual rate (CAGR) of 65% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Spangen Laboratories Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address110 DLF Tower 15 Shivaji Marg, New Delhi, Delhi, India – 110015
- IndustryBusiness Outsourcing, Business & IT Consulting
To see the full contact details of Spangen Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Spangen Laboratories Private Limited
FY 2025 filings availableSpangen Laboratories Private Limited reported revenue of ₹94,957 (down 13% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 65% over three years, including a 13% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹94,957 | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹10,000 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹15,295 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -10.5% | ||
| Net Profit Margin | 16.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Spangen Laboratories Private Limited, buy the company report.
Board of directors of Spangen Laboratories Private Limited
Spangen Laboratories has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinod Suri Also directs: Span Generics Private Limited, Stride Exports Private Limited | Director | 20 Feb 2022 | 4 Years 8 Months | Current |
| Deepti Ajmani Also directs: Span Generics Private Limited | Director | 16 Jan 2008 | 18 Years 9 Months | Current |
Auditor
Spangen Laboratories Private Limited is audited by V A T S S & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V A T S S & ASSOCIATES | FY 2017 | 017573N |
Shareholding
The shareholding of Spangen Laboratories Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Spangen Laboratories Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Spangen Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Spangen Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Spangen Laboratories Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Spangen Laboratories Private Limited has 4 board changes on record since 2008: 2 appointments and 2 cessations. The latest: Kulbhushan Kumar Suri ceased to be Additional Director on 25 Feb 2022.
Frequently asked questions
Spangen Laboratories is an active private limited company based in New Delhi, Delhi, India. The company works in business and IT consulting, within the business outsourcing industry. It was incorporated on 16 January 2008 (18+ years old) and is registered under CIN U93030DL2008PTC172763.
Spangen Laboratories has 2 current directors:
- Vinod Suri - Director
- Deepti Ajmani - Director
The latest financial statements of Spangen Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Spangen Laboratories is U93030DL2008PTC172763. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spangen Laboratories was incorporated on 16 January 2008, making it 18+ years old. It is registered with the Registrar of Companies, Delhi.
Kulbhushan Kumar Suri ceased to be Additional Director on 25 Feb 2022. Vinod Suri was appointed as Director on 20 Feb 2022. Sandeep Kumar Ajmani ceased to be Director on 03 Dec 2020. Spangen Laboratories has 4 board changes on record in total.
The registered office of Spangen Laboratories is at 110 DLF Tower 15 Shivaji Marg, New Delhi, Delhi, India – 110015.
Spangen Laboratories operates in the business outsourcing industry, in the business and IT consulting segment.
The compliance status of Spangen Laboratories is compliant as of 16 July 2026. The company is actively filing with the Registrar of Companies.
Spangen Laboratories can be reached at its registered office: 110 DLF Tower 15 Shivaji Marg, New Delhi, Delhi, India – 110015.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
